EUR 13.80 For Business Accounts Only

RICARDO PLC. loses on its star level and is downgraded to Slightly Positive

The independent financial analyst theScreener just slightly lowered the general evaluation of RICARDO PLC. (GB), active in the Business Support Services industry. The title has lost a star(s) at the fundamental level and now shows 3 out of 4 stars. Its exposure to market risk remains nonetheless the same and can be still described as defensive. theScreener slightly downgrades the general evaluation to Slightly Positive for the title on account of the lost star(s). As of the analysis date February 14, 2020, the closing price was GBp 768.00 and its potential was estimated at GBp 914.09.
Ricardo PLC

Theratase is a holding company. Through its subsidiaries, Co. is engaged in the development, manufacture, marketing and sale of enzymes and biochemicals to the medical diagnostic and pharmaceutical industries. Co.'s products include Alkaline Phosphatase, Glucose Oxidase, Peroxidase, Deoxyribonuclease and Hyaluronidase.


Empowering Investors

theScreener is the market leader for independent valuations of financial securities, equities, sectors and markets, and new funds. theScreener's ratings, analyses are used by leading banks, asset managers and financial portals.  Approximately 10,000 workstations benefit from theScreener's services, with over millions of customer accounts actively analysed.

  • Worldwide coverage: theScreener analyses cover around 6'500 Stocks, i.e 95% of the world Market Capitalization.  theScreener state of art: We provide
  • theScreener state of art: We provide easy to use and complete analyses over Stocks, including Fundamentals / Technical / Risk/ Peer / Alternatives analyses.
  • For Research Pool community, we provide twice a week around 500 new equity analyses. We produce analyses about equities which have been upgraded or downgraded


Other Reports on these Companies
Other Reports from TheScreener

ResearchPool Subscriptions

Get the most out of your insights

Get in touch